Companies: 10,795·Total market cap: $144.5T
MaxCyte, Inc.

MaxCyte, Inc.

MXCTNASDAQHealthcare● Active
$1.15
+$0.01(+0.88%)
Market Cap$123189923
P/E Ratio
52W High$2.4
52W Low$0.643
Overview

MaxCyte, Inc. (MXCT) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · MXCT · as of Jun 8, 2026

Activity summary

Buy transactions

5

P-Purchase only

Sell transactions

2

12 Months

Buy/Sell ratio

2.50

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 71%Active transactions only · RSU vesting excluded29% Sell ↓

MaxCyte, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

MXCT insider buying and selling by quarter

MXCT insider selling · MXCT insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
1.3M638K0
2025 Q2
2025 Q3
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · MXCT ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

MXCT executive sell shares · MXCT board member insider trading · MXCT insider trading SEC filing

Showing 60 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Ahuja Parmeet

CFO

Award

Date

Apr 15

Shares

187,500

Price

Value

View Form 4 on SEC.gov

Masoud Maher

President and CEO · Director

Award

Date

Mar 27

Shares

300,000

Price

Value

View Form 4 on SEC.gov

Swirsky Douglas J

CHIEF FINANCIAL OFFICER

Sale

Date

Mar 17

Shares

10,142

Price

$0.81

Value

$8K

View Form 4 on SEC.gov

Hemrajani Rekha

Director

Sale

Date

Jun 25

Shares

10,684

Price

$2.09

Value

$22K

View Form 4 on SEC.gov

Swirsky Douglas J

CHIEF FINANCIAL OFFICER

Purchase

Date

Aug 13

Shares

50,000

Price

$1.29

Value

$65K

View Form 4 on SEC.gov

Masoud Maher

President and CEO · Director

Purchase

Date

Aug 13

Shares

75,000

Price

$1.37

Value

$103K

View Form 4 on SEC.gov

Erck Stanley C

Director

Purchase

Date

Aug 13

Shares

100,000

Price

$1.37

Value

$137K

View Form 4 on SEC.gov

DOUGLAS RICHARD

Director

Purchase

Date

Aug 13

Shares

80,000

Price

$1.39

Value

$111K

View Form 4 on SEC.gov

Brooke William W

Director

Purchase

Date

Aug 13

Shares

50,000

Price

$1.29

Value

$65K

View Form 4 on SEC.gov

Johnston John Joseph

Director

Award

Date

Jun 18

Shares

29,210

Price

Value

View Form 4 on SEC.gov

Hemrajani Rekha

Director

Award

Date

Jun 18

Shares

29,210

Price

Value

View Form 4 on SEC.gov

Erck Stanley C

Director

Award

Date

Jun 18

Shares

29,210

Price

Value

View Form 4 on SEC.gov

DOUGLAS RICHARD

Director

Award

Date

Jun 18

Shares

29,210

Price

Value

View Form 4 on SEC.gov

Collins Cynthia

Director

Award

Date

Jun 18

Shares

29,210

Price

Value

View Form 4 on SEC.gov

Brooke William W

Director

Award

Date

Jun 18

Shares

29,210

Price

Value

View Form 4 on SEC.gov

BALTHROP PATRICK J

Director

Award

Date

Jun 18

Shares

29,210

Price

Value

View Form 4 on SEC.gov

Al-Wakeel Yasir B.

Director

Award

Date

Jun 18

Shares

29,210

Price

Value

View Form 4 on SEC.gov

Soleymannezhad Ali

Chief Commercial Officer

Sale

Date

Mar 18

Shares

1,211

Price

$3.18

Value

$4K

View Form 4 on SEC.gov

Sandoval David I.

GENERAL COUNSEL

Sale

Date

Mar 18

Shares

353

Price

$3.18

Value

$1K

View Form 4 on SEC.gov

Swirsky Douglas J

CHIEF FINANCIAL OFFICER

Sale

Date

Mar 18

Shares

6,939

Price

$3.18

Value

$22K

View Form 4 on SEC.gov

Soleymannezhad Ali

Chief Commercial Officer

Award

Date

Mar 14

Shares

34,625

Price

Value

View Form 4 on SEC.gov

Sandoval David I.

GENERAL COUNSEL

Award

Date

Mar 14

Shares

23,125

Price

Value

View Form 4 on SEC.gov

Swirsky Douglas J

CHIEF FINANCIAL OFFICER

Award

Date

Mar 14

Shares

37,500

Price

Value

View Form 4 on SEC.gov

Johnston John Joseph

Director

Option

Date

Jan 27

Shares

3,000

Price

$2.93

Value

$9K

View Form 4 on SEC.gov

Johnston John Joseph

Director

Sale

Date

Jan 27

Shares

3,000

Price

$4.64

Value

$14K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About MXCT insider trading

MXCT insider trades

MaxCyte, Inc. (MXCT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Masoud Maher (President and CEO · Director), Swirsky Douglas J (CHIEF FINANCIAL OFFICER), Hemrajani Rekha (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. MXCT insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For MaxCyte, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

MXCT insider trading · 5 questions

The insiders of MaxCyte, Inc. (MXCT) include executives and directors such as Masoud Maher (President and CEO · Director), Swirsky Douglas J (CHIEF FINANCIAL OFFICER), Hemrajani Rekha (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

MXCT board member insider tradingwho are MXCT insidersMXCT insider rosterMaxCyte, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026